B2Gold Corp. against DSM-Firmenich AG — live side-by-side technical comparison.
Prices as of 2026-09-23T20:00:00+00:00 UTC · updates daily
DSFIR.AS leads 5 of the 5 windows we measure — over 1 month BTG is -6.5% and DSFIR.AS +4.8%; over year to date BTG is +18.6% and DSFIR.AS +39.3%.
| BTG | DSFIR.AS | |
|---|---|---|
| Price | $5.35 | $95.76 |
| 1 day | -4.1% | -1.4%lead |
| 5 days | +4.1% | +4.3%lead |
| 1 month | -6.5% | +4.8%lead |
| 6 months | +31.1% | +64.8%lead |
| Year to date | +18.6% | +39.3%lead |
| 52-week position | 65% of range | 96% of range |
| 52-week range | $3.57–$6.29 | $55.22–$97.36 |
| vs 50-day average | above $4.86 | above $90.70 |
| vs 200-day average | above $4.76 | above $73.33 |
| RSI (14) | 48 | 56 |
| Next earnings | 2026-11-04 | 2026-07-30 |
BTG trades at $5.35, above its 50-day average of $4.86, and above the 200-day at $4.76. It sits at 65% of its 52-week range ($3.57–$6.29); 14-day RSI is 48, in neutral territory; an average session moves it about 4.3%. For levels, the first level overhead is $6.00 (12.2% away) and the first support below is $5.06 (5.4% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
DSFIR.AS trades at $95.76, above its 50-day average of $90.70, and above the 200-day at $73.33. It sits at 96% of its 52-week range ($55.22–$97.36); 14-day RSI is 56, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $97.12 (1.4% away) and the first support below is $90.70 (5.3% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
BTG is the more volatile of the two — an average session moves it 4.3% against 2.3% for DSFIR.AS, so an identical position size carries roughly 1.9× the daily risk.
The comparison turns on those levels: BTG clearing $6.00 or losing $5.06; DSFIR.AS clearing $97.12 or losing $90.70. Until one of them gives way, the relative reading above stands.